Women's Health Study (WHS): A Randomized Trial of Low-Dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer - Related Studies

Women's Health Study (WHS): A Randomized Trial of Low-Dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer

This study is ongoing, but not recruiting participants.

Study NCT00000479. Last updated on September 30, 2008. Information provided by National Heart, Lung, and Blood Institute (NHLBI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Cardiovascular Diseases
		Cerebrovascular Disorders
		Coronary Disease
		Heart Diseases
		Myocardial Infarction
		Myocardial Ischemia
		Vascular Diseases

2	Additional conditions recognized in this trial
		Infarction
		Ischemia

3	More general conditions related to this trial
		Brain Diseases
		Central Nervous System Diseases
		Necrosis
		Nervous System Diseases
		Pathologic Processes

4	Interventions listed in this trial
		Aspirin
		Vitamin E
		Placebo

5	Additional drug interventions recognized in this trial
		Alpha-Tocopherol
		Tocopherol acetate
		Tocopherols

6	More general drug interventions related to this trial
		Analgesics
		Analgesics, Non-Narcotic
		Anti-Inflammatory Agents
		Anti-Inflammatory Agents, Non-Steroidal
		Antioxidants
		Antirheumatic Agents
		Cardiovascular Agents
		Central Nervous System Agents
		Cyclooxygenase Inhibitors
		Enzyme Inhibitors
		Fibrin Modulating Agents
		Fibrinolytic Agents
		Growth Substances
		Hematologic Agents
		Micronutrients
		Molecular Mechanisms of Pharmacological Action
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Platelet Aggregation Inhibitors
		Protective Agents
		Sensory System Agents
		Therapeutic Uses
		Vitamins

7	Sponsors listed in this trial
		National Heart, Lung, and Blood Institute (NHLBI)